As of April 2025 Immunome has a market cap of NZ$0.92 Billion. This makes Immunome the world's 6606th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.92 B | -21.02% |
2024 | NZ$1.16 B | 61.35% |
2023 | NZ$0.72 B | 1612.44% |
2022 | NZ$42.21 M | -81.61% |
2021 | NZ$0.22 B | 62.34% |
2020 | NZ$0.14 B |
On Apr 5th, 2025 the market cap of Immunome was reported to be: